Clinical trial
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
NCT00247962 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00247962 |
|---|---|
| Title | Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis |
| Official title | A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | etanercept, sulphasalazine (SSZ) |
| Enrollment | 566 |
| Start date | Dec 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Nov 2, 2005 |
| Last update posted | Nov 8, 2012 |
| Countries | Australia, Austria, China, Czechia, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Netherlands and 6 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: